LCMS Limited has teamed with 2SD Toxicology Services to strengthen the Biocompatibility of Medical Devices program. In particular LCMS Limited will perform extractable leachable studies on medical devices per ISO 10993-18. This should link to the solution page under the tab – Chemical characterization extractable, and degradation products (note this tab is currently called “ impurity detection “)

LCMS Limited is performing a GLP method validation and clinical analysis using LC/MS/MS for a drug in plasma for a commercial client.

LCMS Limited is performing all the swab testing by LC/MS/MS for a facility decontamination of 7 penicillin’s previously manufactured. Additionally, the new drug products that are manufactured in the decontaminated facility, will be tested by LC/MS/MS to verify the drug products are penicillin free.

LCMS Limited was awarded an ongoing testing contracts to determine the level of gluten (from wheat, barley and rye), present using enzymatic digestion followed by LC/MS/MS in different shipments of ingredients used by food manufacture to make their products.

LCMS Limited together with ClorDySys received a contract for B-lactam decontaminations of a manufacturing facility and the equipment being converted for vaccine production.